The dermal fibroblasts were derived from a skin biopsy taken from a dystrophinopathy patient in Ireland with a deletion of DMD exons 45–47. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.